The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey

Autoři: Mike Armour aff001;  Kenny Lawson aff002;  Aidan Wood aff001;  Caroline A. Smith aff001;  Jason Abbott aff003
Působiště autorů: NICM Health Research Institute, Western Sydney University, Sydney, New South Wales, Australia aff001;  Translational Health Research Institute (THRI), Western Sydney University, Sydney New South Wales, Australia aff002;  School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia aff003
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article



Endometriosis has a significant cost of illness burden in Europe, UK and the USA, with the majority of costs coming from reductions in productivity. However, information is scarce on if there is a differing impact between endometriosis and other causes of chronic pelvic pain, and if there are modifiable factors, such as pain severity, that may be significant contributors to the overall burden.


An online survey was hosted by SurveyMonkey and the link was active between February to April 2017. Women aged 18–45, currently living in Australia, who had either a confirmed diagnosis of endometriosis via laparoscopy or chronic pelvic pain without a diagnosis of endometriosis were included. The retrospective component of the WERF EndoCost tool was used to determine direct healthcare costs, direct non-healthcare costs (carers) and indirect costs due to productivity loss. Estimates were extrapolated to the Australian population using published prevalence estimates.


407 valid responses were received. The cost of illness burden was significant in women with chronic pelvic pain (Int $16,970 to $ 20,898 per woman per year) irrespective of whether they had a diagnosis of endometriosis. The majority of costs (75–84%) were due to productivity loss. Both absolute and relative productivity costs in Australia were higher than previous estimates based on data from Europe, UK and USA. Pain scores showed the strongest relationship to productivity costs, a 12.5-fold increase in costs between minimal to severe pain. The total economic burden per year in Australia in the reproductive aged population (at 10% prevalence) was 6.50 billion Int $.


Similar to studies in European, British and American populations, productivity costs are the greatest contributor to overall costs. Given pain is the most significant contributor, priority should be given to improving pain control in women with pelvic pain

Klíčová slova:

Australia – Economic impact analysis – Economics – Europe – Health economics – Public and occupational health – Social media – Women's health


1. Howard F, Perry P, Carter J, El-Minawi A. Pelvic Pain: diagnosis and management. Philadelphia: Lippincott Williams and Wilkins; 2000.

2. Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348:g1752. Epub 2014/03/22. doi: 10.1136/bmj.g1752 24647161.

3. Whitaker LH, Reid J, Choa A, McFee S, Seretny M, Wilson J, et al. An Exploratory Study into Objective and Reported Characteristics of Neuropathic Pain in Women with Chronic Pelvic Pain. PLoS One. 2016;11(4):e0151950. Epub 2016/04/06. doi: 10.1371/journal.pone.0151950 27046128; PubMed Central PMCID: PMC4821621.

4. Mowers EL, Lim CS, Skinner B, Mahnert N, Kamdar N, Morgan DM, et al. Prevalence of Endometriosis During Abdominal or Laparoscopic Hysterectomy for Chronic Pelvic Pain. Obstet Gynecol. 2016;127(6):1045–53. Epub 2016/05/10. doi: 10.1097/AOG.0000000000001422 27159755.

5. Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17(2):E141–7. Epub 2014/03/25. 24658485.

6. Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. Epub 2015/06/13. doi: 10.1016/S0140-6736(15)60692-4 26063472; PubMed Central PMCID: PMC4561509.

7. Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177–200. Epub 2004/05/26. doi: 10.1016/j.bpobgyn.2004.01.007 15157637.

8. Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292–9. Epub 2012/03/17. doi: 10.1093/humrep/des073 22422778.

9. Soliman AM, Taylor HS, Bonafede M, Nelson JK, Castelli-Haley J. Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fertil Steril. 2017;107(5):1181–90 e2. Epub 2017/05/10. doi: 10.1016/j.fertnstert.2017.03.020 28476181.

10. Kalseth J, Halvorsen T, Kalseth B, Sarheim Anthun K, Peltola M, Kautiainen K, et al. Cross-country comparisons of health-care costs: the case of cancer treatment in the Nordic countries. Health Policy. 2014;115(2–3):172–9. Epub 2014/01/28. doi: 10.1016/j.healthpol.2014.01.003 24462342.

11. Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D'Hooghe T, et al. Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Obstet Invest. 2011;71(3):170–6. Epub 2010/12/17. doi: 10.1159/000316055 21160141.

12. Australian Bureau of Statistics. 1249.0—Australian Standard Classification of Cultural and Ethnic Groups (ASCCEG) 2016 [cited 2018 17th April]. Available from:

13. Stromberg C, Aboagye E, Hagberg J, Bergstrom G, Lohela-Karlsson M. Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment-Related Problems on Reductions in Productivity from a Managerial Perspective. Value Health. 2017;20(8):1058–64. Epub 2017/10/02. doi: 10.1016/j.jval.2017.05.008 28964437.

14. Rascati KL, Smith MJ, Neilands T. Dealing with skewed data: an example using asthma-related costs of medicaid clients. Clin Ther. 2001;23(3):481–98. Epub 2001/04/25. doi: 10.1016/s0149-2918(01)80052-7 11318082.

15. The World Bank. PPP conversion factor, GDP (LCU per international $) 2015. Available from:

16. Australian Bureau of Statistics. 3101.0—Australian Demographic Statistics, Dec 2017 2018 [updated Thurs 21 Jun 20182nd July 2018]. Available from:

17. Klein S, D'Hooghe T, Meuleman C, Dirksen C, Dunselman G, Simoens S. What is the societal burden of endometriosis-associated symptoms? a prospective Belgian study. Reprod Biomed Online. 2014;28(1):116–24. Epub 2013/11/26. doi: 10.1016/j.rbmo.2013.09.020 24268732.

18. Stuckler D, Reeves A, McKee M. Social and economic multipliers: What they are and why they are important for health policy in Europe. Scand J Public Health. 2017;45(18_suppl):17–21. Epub 2017/08/30. doi: 10.1177/1403494817707124 28850011.

19. Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366–73 e8. Epub 2011/07/02. doi: 10.1016/j.fertnstert.2011.05.090 21718982; PubMed Central PMCID: PMC3679489.

20. De Graaff AA, Dirksen CD, Simoens S, De Bie B, Hummelshoj L, D'Hooghe TM, et al. Quality of life outcomes in women with endometriosis are highly influenced by recruitment strategies. Hum Reprod. 2015;30(6):1331–41. Epub 2015/04/25. doi: 10.1093/humrep/dev084 25908657.

21. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354 e1- e12. Epub 2019/01/10. doi: 10.1016/j.ajog.2018.12.039 30625295.

22. Winkel CA. Modeling of medical and surgical treatment costs of chronic pelvic pain: new paradigms for making clinical decisions. Am J Manag Care. 1999;5(5 Suppl):S276–90. Epub 1999/10/28. 10537662.

23. Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani P. Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Human Reproduction. 2006;22(1):266–71. doi: 10.1093/humrep/del339 16936305

24. Abbott JA, Hawe J, Clayton RD, Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2–5 year follow-up. Hum Reprod. 2003;18(9):1922–7. Epub 2003/08/19. doi: 10.1093/humrep/deg275 12923150.

25. Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82(4):878–84. Epub 2004/10/16. doi: 10.1016/j.fertnstert.2004.03.046 15482763.

26. Fedele L, Parazzini F, Bianchi S, Arcaini L, Candiani GB. Stage and localization of pelvic endometriosis and pain. Fertil Steril. 1990;53(1):155–8. Epub 1990/01/01. doi: 10.1016/s0015-0282(16)53232-4 2400415.

27. Soliman AM, Coyne KS, Gries KS, Castelli-Haley J, Snabes MC, Surrey ES. The Effect of Endometriosis Symptoms on Absenteeism and Presenteeism in the Workplace and at Home. J Manag Care Spec Pharm. 2017;23(7):745–54. Epub 2017/06/27. doi: 10.18553/jmcp.2017.23.7.745 28650252.

28. Langley P, Muller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ. 2010;13(4):662–72. Epub 2010/11/03. doi: 10.3111/13696998.2010.529379 21034378.

29. Chalmers KJ, Catley MJ, Evans SF, Moseley GL. Clinical assessment of the impact of pelvic pain on women. Pain. 2017;158(3):498–504. Epub 2017/01/31. doi: 10.1097/j.pain.0000000000000789 28135211.

30. Moradi M, Parker M, Sneddon A, Lopez V, Ellwood D. Impact of endometriosis on women's lives: a qualitative study. BMC women's health. 2014;14(1):123. Epub 2014/10/05. doi: 10.1186/1472-6874-14-123 25280500; PubMed Central PMCID: PMC4287196.

31. Huntington A, Gilmour JA. A life shaped by pain: women and endometriosis. J Clin Nurs. 2005;14(9):1124–32. Epub 2005/09/17. doi: 10.1111/j.1365-2702.2005.01231.x 16164530.

32. Brown J, Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014;(3):CD009590. Epub 2014/03/13. doi: 10.1002/14651858.CD009590.pub2 24610050.

33. Sinaii N, Cleary SD, Younes N, Ballweg ML, Stratton P. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277–86. Epub 2007/02/14. doi: 10.1016/j.fertnstert.2006.11.051 17296195.

34. Gerlinger C, Schumacher U, Faustmann T, Colligs A, Schmitz H, Seitz C. Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials. Health Qual Life Outcomes. 2010;8:138. Epub 2010/11/26. doi: 10.1186/1477-7525-8-138 21106059; PubMed Central PMCID: PMC3002916.

35. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–21. Epub 2007/12/07. doi: 10.1016/j.jpain.2007.09.005 18055266.

36. Hansen KE, Kesmodel US, Baldursson EB, Schultz R, Forman A. The influence of endometriosis-related symptoms on work life and work ability: a study of Danish endometriosis patients in employment. Eur J Obstet Gynecol Reprod Biol. 2013;169(2):331–9. Epub 2013/03/30. doi: 10.1016/j.ejogrb.2013.03.008 23537616.

37. Guo SW, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest. 2006;62(3):121–30. Epub 2006/05/06. doi: 10.1159/000093019 16675908.

38. Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D'Hooghe TM. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Hum Reprod Update. 2013;19(5):570–82. Epub 2013/06/04. doi: 10.1093/humupd/dmt016 23727940.

39. Armour M, Sinclair J, Chalmers KJ, Smith CA. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complementary and Alternative Medicine. 2019;19(1):17. doi: 10.1186/s12906-019-2431-x 30646891

40. Australian Bureau of Statistics. 4125.0—Gender Indicators 2018 [updated 25/09/2018]. Available from:

41. Australian Bureau of Statistics. 4364.0.55.002 Australian Health Survey: Health Service Usage and Health Related Actions, 2011–12 2013 [cited 2019]. Available from:

Článek vyšel v časopise


2019 Číslo 10
Nejčtenější tento týden